Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Impaired Renal Function”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01377246
What this trial is testing

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mario Negri Institute for Pharmacological Research 100
Testing effectiveness (Phase 2)Ended earlyNCT00150319
What this trial is testing

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

Who this might be right for
Kidney Failure
Pfizer 1
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Early research (Phase 1)Study completedNCT06352411
What this trial is testing

Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

Who this might be right for
HealthyRenal Impairment
Boehringer Ingelheim 42
Post-approval studies (Phase 4)UnknownNCT04776187
What this trial is testing

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Who this might be right for
Nephrogenic Fibrosing Dermopathy
The Central Hospital of Lishui City 600
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Early research (Phase 1)Study completedNCT02634437
What this trial is testing

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Who this might be right for
Renal Function
Allergan 19
Early research (Phase 1)Study completedNCT05954169
What this trial is testing

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT02679131
What this trial is testing

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Who this might be right for
Relapsed/Refractory Solid Tumors/Hematological Malignancies
Acrotech Biopharma Inc. 18
Not applicableLooking for participantsNCT03547414
What this trial is testing

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

Who this might be right for
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens 110
Not applicableStudy completedNCT02863510
What this trial is testing

Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease

Who this might be right for
HypertensionChronic Kidney Disease
Heart of England NHS Trust 10
Large-scale testing (Phase 3)Study completedNCT02836873
What this trial is testing

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Theracos 312
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Large-scale testing (Phase 3)Study completedNCT05075408
What this trial is testing

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

Who this might be right for
Chronic Kidney Disease Associated Moderate to Severe Pruritus
Galderma R&D 258
Early research (Phase 1)Study completedNCT06132204
What this trial is testing

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 16
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Early research (Phase 1)WithdrawnNCT05541159
What this trial is testing

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT07227922
What this trial is testing

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Who this might be right for
Moderate Renal Impairment
Sparrow Pharmaceuticals 16
Early research (Phase 1)Study completedNCT01763190
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Study completedNCT01136564
What this trial is testing

Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Erling Bjerregaard Pedersen 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation